Related references
Note: Only part of the references are listed.PRNCR1: a long non-coding RNA with a pivotal oncogenic role in cancer
Abhishek Bardhan et al.
HUMAN GENETICS (2022)
Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells
Ganesan Arunkumar et al.
SCIENCE ADVANCES (2022)
Correlation between Genomic Variants and Worldwide Epidemiology of Prostate Cancer
Giovana Miranda Vieira et al.
GENES (2022)
Circulating Insulin-Like Growth Factor 1-Related Biomarkers and Risk of Lethal Prostate Cancer
Chaoran Ma et al.
JNCI CANCER SPECTRUM (2022)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
David Conti et al.
NATURE GENETICS (2021)
Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
Indu Kohaar et al.
Oncotarget (2020)
Multi-ethnic transcriptome-wide association study of prostate cancer
Peter N. Fiorica et al.
PLOS ONE (2020)
The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management
Varune Rohan Ramnarine et al.
EUROPEAN UROLOGY (2019)
Ethnicity and ERG frequency in prostate cancer
Jason Sedarsky et al.
NATURE REVIEWS UROLOGY (2018)
A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
Sarah Benafif et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort
Jennifer Cullen et al.
EUROPEAN UROLOGY FOCUS (2018)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou et al.
NATURE (2017)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Roger L. Milne et al.
NATURE GENETICS (2017)
RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data
Xiaowei Zhan et al.
BIOINFORMATICS (2016)
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes
Kathryn L. Penney et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Next-generation genotype imputation service and methods
Sayantan Das et al.
NATURE GENETICS (2016)
Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status
Lieke Egbers et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors
Milan S. Geybels et al.
CLINICAL EPIGENETICS (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer
Jacob B. Hjelmborg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
Alexander W. Wyatt et al.
GENOME BIOLOGY (2014)
Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men
James Farrell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Changmeng Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Montserrat Garcia-Closas et al.
NATURE GENETICS (2013)
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
Andreas Pettersson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus
Xiaoyang Zhang et al.
GENOME RESEARCH (2012)
A linear complexity phasing method for thousands of genomes
Olivier Delaneau et al.
NATURE METHODS (2012)
Genome-wide DNA Methylation Events in TMPRSS2-ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
Stefan T. Boerno et al.
CANCER DISCOVERY (2012)
Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
Alcides Chaux et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Genome-wide association study identifies new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
HUMAN MOLECULAR GENETICS (2011)
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
Geert J. L. H. van Leenders et al.
MODERN PATHOLOGY (2011)
METAL: fast and efficient meta-analysis of genomewide association scans
Cristen J. Willer et al.
BIOINFORMATICS (2010)
Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes
Manuel Luedeke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Statin use and risk of prostate cancer: Results from a population-based epidemiologic study
Ilir Agalliu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays
Brenda Summersgill et al.
NATURE PROTOCOLS (2008)
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
R. K. Nam et al.
BRITISH JOURNAL OF CANCER (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Share Paper
